MedPath

Pilot Feasibility Study of Peristomal Adhesives

Not Applicable
Completed
Conditions
Laryngectomy; Status
Interventions
Other: Moldable adhesive
Registration Number
NCT05762497
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

Loss of voice is one of the greater consequences of total laryngectomy. The voice prosthesis allows the patients to speak again in a very short time but forces them to use one hand when speaking. In order to reduce this discomfort and to allow "hands-free" speaking, an Automatic Speaking Valve (ASV) has been designed which is positioned on a peristomal adhesive.

Peristomal adhesives, however, tend to detach under the influence of mucus, cough, or phonatory pressure. Consequently, the current regular use of the automatic speaking valve in laryngectomees is very low. As a possible solution, Atos Medical AB has developed a moldable peristomal adhesive made of a thermoplastic elastomer, which becomes transparent and moldable when heated and facilitates precise contouring in situ. As the material cools, it loses its malleability but retains the integrity of the molded shape.

The expectation was that the moldable adhesive would provide a better individual fit and therefore longer fixation (especially when using the ASV).

To study the feasibility of this device, 10 total laryngectomized patients were asked to use the new moldable peristomal adhesive for two weeks in conjunction with their normal daily routine for adhesive application and removal, and speech rehabilitation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Have undergone total laryngectomy
  • Over the age of 18
  • voice prosthesis user
  • Experience in the use of adhesive and HMEs
  • At least 3 months after total laryngectomy
  • At least 6 months after the end of adjuvant radiotherapy
  • Signature of the informed consent
Exclusion Criteria
  • Medical issues that prevent the use of HMEs and/or adhesives
  • Recurrent or metastatic active disease
  • Reduced mobility of the arms and/or hands
  • Inability to understand the information and/or to provide informed consent
  • Insufficient cognitive ability to handle HME or moldable adhesive

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Laryngectomized patientsMoldable adhesive-
Primary Outcome Measures
NameTimeMethod
Investigation about product performance2 weeks

Duration of hands-free speech \[hours/day\]

Secondary Outcome Measures
NameTimeMethod
Parameters were expected to influence product performance and patient preference2 weeks

Adhesives usability (scored on a 5-point Likert scale),

Trial Locations

Locations (1)

Fondazione Policlinico Universitario A. Gemelli - IRCCS

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath